Trial · NCT02658890
Adverse events20,820
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 20,820Pages stop at row 10,000
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Part 1: BMS50 (ESC) | 0 | 1 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1: BMS400 (ESC) | 0 | 1 | |
| other | Anaemia | Blood and lymphatic system disorders | Unplanned - BMS50 | 0 | 1 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1: BMS25+NIV240(ESC) | 1 | 7 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1: BMS50+NIV240(ESC) | 2 | 10 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1: BMS100+NIV240(ESC) | 6 | 12 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1: BMS200+NIV240(ESC) | 7 | 18 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 1: BMS400+NIV240(ESC | 2 | 6 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 2: Exp Cervical + (IDO 100) | 5 | 18 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 2: Exp Cervical + (IDO 200) | 4 | 17 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 2: Exp Pancreatic | 4 | 22 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 2: Exp DLBCL | 7 | 35 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 2: Exp SCCHN + (IDO 100) | 2 | 15 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 2: Exp SCCHN + (IDO 200) | 1 | 14 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 2: Exp Bladder + (IDO 100) | 3 | 14 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 2: Exp Bladder + (IDO 200) | 3 | 16 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 2: Exp ML I-O Naive | 9 | 79 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 2: Exp ML BRAF-MT | 3 | 9 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 2: Exp ML BRAF-MT- NIVO | 0 | 6 | |
| other | Anaemia | Blood and lymphatic system disorders | Part 2: Exp ML Anti-PDL1 | 2 | 37 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02658890/events